Search

Search Constraints

You searched for: Author/Creator Maceski, Aleksandra

Search Results

11. Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin‐related amyloidosis—A Swiss reference center experience. Issue 1 (11th December 2022)

12. Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study. Issue 3 (March 2022)

13. Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing–remitting MS. (April 2022)